A decade of molecular pathogenomic analysis of group A Streptococcus

Journal of Clinical Investigation

Volumn 119, Issue 9, 2009, Pages 2455-2463

  Musser, James M ^a   Shelburne III, Samuel A ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; DNA MICROARRAY; DNA SEQUENCE; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; STREPTOCOCCUS GROUP A;

GENE TRANSFER, HORIZONTAL; GENOME, BACTERIAL; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR EPIDEMIOLOGY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; SYSTEMS BIOLOGY; VIRULENCE; VIRULENCE FACTORS;

EID: 70349223864     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38095     Document Type: Review

References (125)

1. Olsen, R.J., Shelburne, S.A., and Musser, J.M. 2009. Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol. 11:1-12.
2. Pichichero, M.E. 1998. Group A beta-hemolytic streptococcal infections. Pediatr. Rev. 19:291-302.
3. Carapetis, J.R., Steer, A.C., Mulholland, E.K., and Weber, M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694. (Pubitemid 41505357)
4. Carapetis, J.R., McDonald, M., and Wilson, N.J. 2005. Acute rheumatic fever. Lancet. 366:155-168.
5. Tanz, R.R., et al. 2004. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin. Infect. Dis. 39:1794-1801.
6. Robinson, D.A., Sutcliffe, J.A., Tewodros, W., Manoharan, A., and Bessen, D.E. 2006. Evolution and global dissemination of macrolide-resistant group A streptococci. Antimicrob. Agents Chemother. 50:2903-2911. (Pubitemid 44396391)
7. Martin, J.M., Green, M., Barbadora, K.A., and Wald, E.R. 2002. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346:1200-1206. (Pubitemid 34984581)
8. Reid, S.D., Virtaneva, K., and Musser, J.M. 2003. Group A Streptococcus vaccine research: historical synopsis and new insights. In Bacterial vaccines. R.W. Ellis and B.R. Brodeur, editors. Landes Bioscience. Austin, Texas, USA. pp. 155-173.
9. Bisno, A.L., Rubin, F.A., Cleary, P.P., and Dale, J.B. 2005. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles - report of a National Institute of Allergy and Infectious Diseases workshop. Clin. Infect. Dis. 41:1150-1156.
10. Musser, J.M., and DeLeo, F.R. 2005. Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. Am. J. Pathol. 167:1461-1472.
11. Whittam, T.S., and Bumbaugh, A.C. 2002. Inferences from whole-genome sequences of bacterial pathogens. Curr. Opin. Genet. Dev. 12:719-725.
12. Blattner, F.R., et al. 1997. The complete genome sequence of Escherichia coli K-12. Science. 277:1453-1474.
13. Perna, N.T., et al. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature. 409:529-533. (Pubitemid 32144360)
14. Welch, R.A., et al. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020-17024.
15. Beres, S.B., and Musser, J.M. 2007. Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS ONE. 2:e800.
16. Ochman, H., Lerat, E., and Daubin, V. 2005. Examining bacterial species under the specter of gene transfer and exchange. Proc. Natl. Acad. Sci. U. S. A. 102(Suppl. 1):6595-6599. (Pubitemid 40628309)
17. Beres, S.B., et al. 2006. Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 103:7059-7064.
18. Kennedy, A.D., et al. 2008. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc. Natl. Acad. Sci. U. S. A. 105:1327-1332.
19. Beres, S.B., et al. 2004. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc. Natl. Acad. Sci. U. S. A. 101:11833-11838.
20. McShan, W.M., et al. 2008. Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes. J. Bacteriol. 190:7773-7785.
21. Holden, M.T., et al. 2007. Complete genome of acute rheumatic fever-associated serotype M5 Streptococcus pyogenes strain Manfredo. J. Bacteriol. 189:1473-1477.
22. Sumby, P., et al. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192:771-782. (Pubitemid 41193074)
23. Green, N.M., et al. 2005. Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192:760-770.
24. Banks, D.J., et al. 2004. Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J. Infect. Dis. 190:727-738.
25. Nakagawa, I., et al. 2003. Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. Genome Res. 13:1042-1055. (Pubitemid 36764186)
26. Smoot, J.C., et al. 2002. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. U. S. A. 99:4668-4673.
27. Beres, S.B., et al. 2002. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. U. S. A. 99:10078-10083.
28. Ferretti, J.J., et al. 2001. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 98:4658-4663. (Pubitemid 32295032)
29. Shulman, S.T., et al. 2004. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin. Infect. Dis. 39:325-332.
30. O'Loughlin, R.E., et al. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862. (Pubitemid 47580376)
31. Luca-Harari, B. et al. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. In press.
32. Abbot, E.L., et al. 2007. Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin. Cell. Microbiol. 9:1822-1833.
33. Mora, M., et al. 2005. Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc. Natl. Acad. Sci. U. S. A. 102:15641-15646. (Pubitemid 41528109)
34. Sitkiewicz, I., et al. 2006. Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc. Natl. Acad. Sci. U. S. A. 103:16009-16014. (Pubitemid 44657583)
35. Zhang, S., Green, N.M., Sitkiewicz, I., Lefebvre, R.B., and Musser, J.M. 2006. Identification and characterization of an antigen I/II family protein produced by group A Streptococcus. Infect. Immun. 74:4200-4213. (Pubitemid 43993354)
36. Manetti, A.G., et al. 2007. Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol. Microbiol. 64:968-983.
37. Edwards, R.J., et al. 2005. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J. Infect. Dis. 192:783-790.
38. Coye, L.H., and Collins, C.M. 2004. Identification of SpyA, a novel ADP-ribosyltransferase of Streptococcus pyogenes. Mol. Microbiol. 54:89-98.
39. Collin, M., and Olsen, A. 2001. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J. 20:3046-3055. (Pubitemid 32611992)
40. von Pawel-Rammingen, U., Johansson, B.P., and Bjorck, L. 2002. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21:1607-1615. (Pubitemid 34614617)
41. Rasmussen, M., Eden, A., and Bjorck, L. 2000. SclA, a novel collagen-like surface protein of Streptococcus pyogenes. Infect. Immun. 68:6370-6377. (Pubitemid 30800310)
42. Malke, H., Steiner, K., McShan, W.M., and Ferretti, J.J. 2006. Linking the nutritional status of Streptococcus pyogenes to alteration of transcriptional gene expression: the action of CodY and RelA. Int. J. Med. Microbiol. 296:259-275. (Pubitemid 44016160)
43. Sumby, P., et al. 2005. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 102:1679-1684. (Pubitemid 40209227)
44. Rasmussen, M., and Bjorck, L. 2001. Unique regulation of SclB - a novel collagen-like surface protein of Streptococcus pyogenes. Mol. Microbiol. 40:1427-1438. (Pubitemid 32635310)
45. Shelburne, S.A., 3rd, et al. 2006. Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect. Immun. 74:4605-4614.
46. Sumby, P., et al. 2008. A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect. Immun. 76:978-985. (Pubitemid 40209227)
47. Hidalgo-Grass, C., et al. 2006. A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues. EMBO J. 25:4628-4637. (Pubitemid 44498135)
48. Zinkernagel, A.S., et al. 2008. The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe. 4:170-178.
49. Sjolinder, H., et al. 2008. The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model. Infect. Immun. 76:3959-3966.
50. Rodriguez-Ortega, M.J., et al. 2006. Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat. Biotechnol. 24:191-197.
51. Lei, B., et al. 2002. Opsonophagocytosis-inhibiting Mac protein of group A Streptococcus: identification and characteristics of two genetic complexes. Infect. Immun. 70:6880-6890. (Pubitemid 35387921)
52. Caswell, C.C., Lukomska, E., Seo, N.S., Hook, M., and Lukomski, S. 2007. Scl1-dependent internalization of group A Streptococcus via direct interactions with the alpha2beta(1) integrin enhances pathogen survival and re-emergence. Mol. Microbiol. 64:1319-1331. (Pubitemid 46849020)
53. Proft, T., Moffatt, S.L., Berkahn, C.J., and Fraser, J.D. 1999. Identification and characterization of novel superantigens from Streptococcus pyogenes. J. Exp. Med. 189:89-102. (Pubitemid 29047029)
54. Unnikrishnan, M., et al. 2002. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J. Immunol. 169:2561-2569. (Pubitemid 34921001)
55. Proft, T., Webb, P.D., Handley, V., and Fraser, J.D. 2003. Two novel superantigens found in both group A and group C Streptococcus. Infect. Immun. 71:1361-1369. (Pubitemid 36254322)
56. Kreikemeyer, B., McIver, K.S., and Podbielski, A. 2003. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol. 11:224-232. (Pubitemid 36645006)
57. Levin, J.C., and Wessels, M.R. 1998. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol. Microbiol. 30:209-219.
58. Dalton, T.L., Collins, J.T., Barnett, T.C., and Scott, J.R. 2006. RscA, a member of the MDR1 family of transporters, is repressed by CovR and required for growth of Streptococcus pyogenes under heat stress. J. Bacteriol. 188:77-85.
59. Graham, M.R., et al. 2002. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc. Natl. Acad. Sci. U. S. A. 99:13855-13860.
60. Voyich, J.M., et al. 2004. Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense. J. Immunol. 173:1194-1201.
61. Ribardo, D.A., Lambert, T.J., and McIver, K.S. 2004. Role of Streptococcus pyogenes two-component response regulators in the temporal control of Mga and the Mga-regulated virulence gene emm. Infect. Immun. 72:3668-3673.
62. Sitkiewicz, I., and Musser, J.M. 2006. Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group A Streptococcus. Infect. Immun. 74:1339-1351. (Pubitemid 43185573)
63. Chaussee, M.S., et al. 2002. Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect. Immun. 70:762-770.
64. Kreikemeyer, B., et al. 2007. The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional regulatory network and its control of virulence factor expression from the novel eno ralp3 epf sagA pathogenicity region. Infect. Immun. 75:5698-5710. (Pubitemid 350207806)
65. Gryllos, I., et al. 2008. PerR confers phagocytic killing resistance and allows pharyngeal colonization by group A Streptococcus. PLoS Pathog. 4:e1000145.
66. Kinkel, T.L., and McIver, K.S. 2008. CcpA-mediated repression of streptolysin S expression and virulence in the group A Streptococcus. Infect. Immun. 76:3451-3463.
67. Roberts, S.A., and Scott, J.R. 2007. RivR and the small RNA RivX: the missing links between the CovR regulatory cascade and the Mga regulon. Mol. Microbiol. 66:1506-1522.
68. Ribardo, D.A., and McIver, K.S. 2006. Defining the Mga regulon: Comparative transcriptome analysis reveals both direct and indirect regulation by Mga in the group A Streptococcus. Mol. Microbiol. 62:491-508.
69. Ryan, P.A., Kirk, B.W., Euler, C.W., Schuch, R., and Fischetti, V.A. 2007. Novel algorithms reveal streptococcal transcriptomes and clues about undefined genes. PLoS Comput. Biol. 3:e132. (Pubitemid 47196163)
70. Loughman, J.A., and Caparon, M. 2006. Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression. J. Bacteriol. 188:399-408. (Pubitemid 43100527)
71. Chaussee, M.A., Dmitriev, A.V., Callegari, E.A., and Chaussee, M.S. 2008. Growth phase-associated changes in the transcriptome and proteome of Streptococcus pyogenes. Arch. Microbiol. 189:27-41.
72. Beyer-Sehlmeyer, G., Kreikemeyer, B., Horster, A., and Podbielski, A. 2005. Analysis of the growth phase-associated transcriptome of Streptococcus pyogenes. Int. J. Med. Microbiol. 295:161-177.
73. Voyich, J.M., et al. 2003. Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U. S. A. 100:1996-2001.
74. Shelburne, S.A., 3rd, et al. 2008. A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 105:1698-1703.
75. Virtaneva, K., et al. 2005. Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc. Natl. Acad. Sci. U. S. A. 102:9014-9019. (Pubitemid 40881070)
76. Graham, M.R., et al. 2006. Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am. J. Pathol. 169:927-942.
77. Shelburne, S.A., 3rd, et al. 2005. Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc. Natl. Acad. Sci. U. S. A. 102: 16037-16042.
78. Graham, M.R., et al. 2005. Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am. J. Pathol. 166:455-465.
79. Loughman, J.A., and Caparon, M.G. 2006. A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. EMBO J. 25:5414-5422.
80. Loughman, J.A., and Caparon, M.G. 2007. Comparative functional analysis of the lac operons in Streptococcus pyogenes. Mol. Microbiol. 64:269-280.
81. Hanks, T.S., et al. 2006. Differential regulation of iron- and manganese-specific MtsABC and hemespecific HtsABC transporters by the metalloregulator MtsR of group A Streptococcus. Infect. Immun. 74:5132-5139.
82. Ricci, S., Janulczyk, R., and Bjorck, L. 2002. The regulator PerR is involved in oxidative stress response and iron homeostasis and is necessary for full virulence of Streptococcus pyogenes. Infect. Immun. 70:4968-4976. (Pubitemid 34907307)
83. Brenot, A., King, K.Y., and Caparon, M.G. 2005. The PerR regulon in peroxide resistance and virulence of Streptococcus pyogenes. Mol. Microbiol. 55:221-234. (Pubitemid 40127898)
84. Peter, G., and Smith, A.L. 1977. Group A streptococcal infections of the skin and pharynx (first of two parts). N. Engl. J. Med. 297:311-317. (Pubitemid 8161786)
85. Bessen, D.E., and Kalia, A. 2002. Genomic localization of a T serotype locus to a recombinatorial zone encoding extracellular matrix-binding proteins in Streptococcus pyogenes. Infect. Immun. 70:1159-1167. (Pubitemid 34163387)
86. Bessen, D.E., Sotir, C.M., Readdy, T.L., and Hollingshead, S.K. 1996. Genetic correlates of throat and skin isolates of group A streptococci. J. Infect. Dis. 173:896-900.
87. Kratovac, Z., Manoharan, A., Luo, F., Lizano, S., and Bessen, D.E. 2007. Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes. J. Bacteriol. 189:1299-1310. (Pubitemid 46239751)
88. Hung, C.S., et al. 2002. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol. Microbiol. 44:903-915. (Pubitemid 34535528)
89. Haukness, H.A., et al. 2002. The heterogeneity of endemic community pediatric group A streptococcal pharyngeal isolates and their relationship to invasive isolates. J. Infect. Dis. 185:915-920.
90. Hoe, N.P., et al. 2001. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. J. Infect. Dis. 183:633-639.
91. Sumby, P., Whitney, A.R., Graviss, E.A., DeLeo, F.R., and Musser, J.M. 2006. Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2:e5.
92. Walker, M.J., et al. 2007. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat. Med. 13:981-985.
93. Engleberg, N.C., Heath, A., Miller, A., Rivera, C., and DiRita, V.J. 2001. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J. Infect. Dis. 183:1043-1054. (Pubitemid 32230952)
94. Daubin, V., Moran, N.A., and Ochman, H. 2003. Phylogenetics and the cohesion of bacterial genomes. Science. 301:829-832.
95. Musser, J.M., et al. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. U. S. A. 88:2668-2672.
96. Musser, J.M., et al. 1995. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63:994-1003.
97. Musser, J.M., et al. 1993. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J. Infect. Dis. 167:337-346.
98. Aziz, R.K., et al. 2005. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J. Bacteriol. 187:3311-3318.
99. Cleary, P.P., et al. 1992. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet. 339:518-521.
100. Chatellier, S., et al. 2000. Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:3523-3534. (Pubitemid 30340453)
101. Norrby-Teglund, A., Nepom, G.T., and Kotb, M. 2002. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur. J. Immunol. 32:2570-2577.
102. Kotb, M., et al. 2002. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8:1398-1404. (Pubitemid 36019425)
103. Sundberg, E., and Jardetzky, T.S. 1999. Structural basis for HLA-DQ binding by the streptococcal superantigen SSA. Nat. Struct. Biol. 6:123-129. (Pubitemid 29069773)
104. Norrby-Teglund, A., et al. 2000. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur. J. Immunol. 30:3247-3255. (Pubitemid 30846041)
105. Nooh, M.M., El-Gengehi, N., Kansal, R., David, C.S., and Kotb, M. 2007. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178:3076-3083. (Pubitemid 46333188)
106. Abdeltawab, N.F., et al. 2008. An unbiased systems genetics approach to mapping genetic loci modulating susceptibility to severe streptococcal sepsis. PLoS Pathog. 4:e1000042.
107. Aziz, R.K., et al. 2007. Susceptibility to severe streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun. 8:404-415.
108. Goldmann, O., et al. 2007. Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect. Immun. 75:4148-4157. (Pubitemid 47206314)
109. Hamilton, S.M., Bayer, C.R., Stevens, D.L., Lieber, R.L., and Bryant, A.E. 2008. Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J. Infect. Dis. 198:1692-1698.
110. Stalhammar-Carlemalm, M., Areschoug, T., Larsson, C., and Lindahl, G. 1999. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol. Microbiol. 33:208-219. (Pubitemid 29304201)
111. Sharkawy, A., et al. 2002. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin. Infect. Dis. 34:454-460. (Pubitemid 34112265)
112. Davies, H.D., et al. 1996. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N. Engl. J. Med. 335:547-554.
113. McCarthy, M.I., et al. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9:356-369. (Pubitemid 351556063)
114. Svensson, M.D., et al. 2000. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol. Microbiol. 38:242-253.
115. Lukomski, S., et al. 1998. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect. Immun. 66:771-776. (Pubitemid 28074226)
116. Jakobsson, M., et al. 2008. Genotype, haplotype and copy-number variation in worldwide human populations. Nature. 451:998-1003. (Pubitemid 351301742)
117. Rinaudo, C.D., Telford, J.L., Rappuoli, R., and Seib, K.L. 2009. Vaccinology in the genome era. J. Clin. Invest. 119:2515-2525.
118. Lei, B., Mackie, S., Lukomski, S., and Musser, J.M. 2000. Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect. Immun. 68:6807-6818. (Pubitemid 32463388)
119. Lei, B., Liu, M., Chesney, G.L., and Musser, J.M. 2004. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins. J. Infect. Dis. 189:79-89. (Pubitemid 38122333)
120. Cole, J.N., et al. 2005. Surface analyses and immune reactivities of major cell wall-associated proteins of group A Streptococcus. Infect. Immun. 73:3137-3146.
121. Severin, A., et al. 2007. Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins. J. Bacteriol. 189:1514-1522. (Pubitemid 46446112)
122. Nakamura, T., et al. 2004. Two-dimensional gel electrophoresis analysis of the abundance of virulent exoproteins of group A Streptococcus caused by environmental changes. Arch. Microbiol. 181:74-81. (Pubitemid 38161239)
123. Zhang, M., et al. 2007. Group A Streptococcus cell-associated pathogenic proteins as revealed by growth in hyaluronic acid-enriched media. Proteomics. 7:1379-1390. (Pubitemid 46775873)
124. Koller, T., et al. 2008. PlyC, a novel bacteriophage lysin for compartment-dependent proteomics of group A streptococci. Proteomics. 8:140-148.
125. Glaser, P., et al. 2002. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45:1499-1513. (Pubitemid 35231970)